Greenrose
(OTC) GNRS
Greenrose Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$50.62M
Net Income (TTM)
$40.10M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
GNRS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Greenrose
Industry
Pharmaceuticals
Sector
Health CareCEO
Timothy Bossidy, MBA
Website
www.greenrosecorp.comHeadquarters
Amityville, NY 11701, US
GNRS Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
39%
Net Income Margin
71%
Return on Equity
15%
Return on Capital
9%
Return on Assets
7%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$15.00M
Operating Income
$9.84M
EBITDA
$22.46M
Operating Cash Flow
$8.19M
Capital Expenditure
$5.55M
Free Cash Flow
$2.64M
Cash & ST Invst.
$8.93M
Total Debt
$108.66M
Greenrose Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$7.85M
N/A
Gross Profit
$2.60M
N/A
Gross Margin
33.16%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
91
N/A
Net Income
$36.03M
-4531.7%
EBITDA
$10.60M
-985.2%
Quarterly Fundamentals
Net Cash
$140.93M
-3663.2%
Accounts Receivable
$1.95M
N/A
Inventory
$11.88M
N/A
Long Term Debt
$9.57M
+247.9%
Short Term Debt
$132.32M
+11983.7%
Return on Assets
7.50%
N/A
Return on Invested Capital
9.10%
N/A
Free Cash Flow
$4.78M
-1054.1%
Operating Cash Flow
$4.60M
-1009.9%